Price History
Feb 9, 2026 — Apr 4, 2026Investment Snapshot
- Trading 11% below Graham Number — thin margin of safety
- Piotroski F-Score 5/9 — moderate financial health
- ROE of 13.8% — below-average profitability
- Revenue growing at 9% annually
METLIFE, INC. (MET) is a Financial Services company operating in Life Insurance, listed on the NYSE , with a market capitalisation of $44.7 billion . Key value metrics: P/E ratio 11.4, P/B ratio 1.58, Piotroski F-Score 5 out of 9 (moderate financial health) .
Value Score
Key Metrics
Current vs 5-Year Average
Based on 5 years of SEC filingsRevenue & Net Income
Financial Statements
| Metric | FY22 | FY23 | FY24 |
|---|---|---|---|
| Revenue | $X.XB | $X.XB | $X.XB |
| Gross Profit | $X.XB | $X.XB | $X.XB |
| Operating Income | $X.XB | $X.XB | $X.XB |
| Net Income | $X.XB | $X.XB | $X.XB |
| EBITDA | $X.XB | $X.XB | $X.XB |
| Total Assets | $X.XB | $X.XB | $X.XB |
| Total Liabilities | $X.XB | $X.XB | $X.XB |
METLIFE, INC. — Fundamental Analysis Summary
METLIFE, INC. (MET) is trading 11% below its Graham Number of $76.67, offering a thin margin of safety. The stock carries a low trailing P/E ratio of 11.4x.
On financial health, MET shows a moderate Piotroski F-Score of 5/9, and modest return on equity of 13.8% (sector average: 5.8%), and manageable leverage with a debt-to-equity ratio of 0.52.
StockPik's composite Value Score for MET is 78/100 — placing it in undervalued territory. The score is built from ten fundamental signals: P/E, P/B, PEG ratio, P/S ratio, return on equity, gross margin, debt-to-equity, current ratio, dividend yield, and Piotroski F-Score.
MET shows revenue growing at 9% year-over-year, with earnings declining at 24%.
MET pays a solid dividend yield of 3.2%.